Daniel Ryweck is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Jun 2024 and Jul 2026: Silo Pharma, Inc. (Sarasota, FL — pharmaceuticals — 2024–2026; $4.28M reported sold to 47 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Eric Weisblum (3 shared filings), Jeff Pavell (3 shared filings), Kevin Munoz (3 shared filings) and Wayne Linsley (3 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
The issuer belongs to the sponsor group Sable Ridge (5 issuers, $44.7M reported sold, 2011–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Sable Ridge has 5 companies on file and $44.7M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Daniel Ryweck and found 1 difference: Same name, different state: "Daniel E. Ryweck" (MN) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.